StreetInsider.com News Articles

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

LONDON & BOSTON--(BUSINESS WIRE)-- Convatec (LSE:CTEC), a leading medical products and technologies company focused on solutions for the management of chronic conditions; The Eli Lilly and Company Foundation (Lilly Foundation), a tax-exempt private foundation supported by donations from Eli Lilly and Company (NYSE:LLY) have committed c.$5 million to Partners In Health (PIH), an international nonprofit global health organization to help accelerate the integration of non‑communicable disease (NCD) and chronic care, including cardiometabolic and mental health, into primary and community health systems in resource-limited settings.

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic Conditions

Tue, 09 Jun 2026 04:00:00 -0400

The financial commitment will enable PIH to scale its integrated models of care and

ConvaTec Group Plc. (CTEC:LN) (CNVVY) PT Lowered to GBP3 at Barclays

Fri, 22 May 2026 05:28:29 -0400

Barclays analyst Hassan Al-Wakeel lowered the price target on ConvaTec Group Plc. (CTEC:LN) (OTC: CNVVY) to GBP3.00 (from GBP3.20) while maintaining a Overweight rating.

ConvaTec Group Plc. (CTEC:LN) (CNVVY) PT Lowered to GBP3 at Barclays

Fri, 22 May 2026 05:28:29 -0400

Barclays analyst Hassan Al-Wakeel lowered the price target on ConvaTec Group Plc. (CTEC:LN) (OTC: CNVVY) to GBP3.00 (from GBP3.20) while maintaining a Overweight rating.

ConvaTec Group Plc. (CTEC:LN) (CNVVY) PT Lowered to GBP3 at Barclays

Fri, 22 May 2026 05:28:29 -0400

Barclays analyst Hassan Al-Wakeel lowered the price target on ConvaTec Group Plc. (CTEC:LN) (OTC: CNVVY) to GBP3.00 (from GBP3.20) while maintaining a Overweight rating.

ConvaTec Group Plc. (CTEC:LN) (CNVVY) PT Lowered to GBP3 at Barclays

Fri, 22 May 2026 05:28:29 -0400

Barclays analyst Hassan Al-Wakeel lowered the price target on ConvaTec Group Plc. (CTEC:LN) (OTC: CNVVY) to GBP3.00 (from GBP3.20) while maintaining a Overweight rating.

ConvaTec Group Plc. (CTEC:LN) (CNVVY) PT Lowered to GBP2.94 at JPMorgan

Fri, 22 May 2026 02:31:39 -0400

JPMorgan analyst Craig McDowell lowered the price target on ConvaTec Group Plc. (CTEC:LN) (OTC: CNVVY) to GBP2.94 (from GBP3.07) while maintaining a Overweight rating.

ConvaTec Group Plc. (CTEC:LN) (CNVVY) PT Lowered to GBP2.94 at JPMorgan

Fri, 22 May 2026 02:31:39 -0400

JPMorgan analyst Craig McDowell lowered the price target on ConvaTec Group Plc. (CTEC:LN) (OTC: CNVVY) to GBP2.94 (from GBP3.07) while maintaining a Overweight rating.

ConvaTec Group Plc. (CTEC:LN) (CNVVY) PT Lowered to GBP2.94 at JPMorgan

Fri, 22 May 2026 02:31:39 -0400

JPMorgan analyst Craig McDowell lowered the price target on ConvaTec Group Plc. (CTEC:LN) (OTC: CNVVY) to GBP2.94 (from GBP3.07) while maintaining a Overweight rating.

ConvaTec Group Plc. (CTEC:LN) (CNVVY) PT Lowered to GBP2.94 at JPMorgan

Fri, 22 May 2026 02:31:39 -0400

JPMorgan analyst Craig McDowell lowered the price target on ConvaTec Group Plc. (CTEC:LN) (OTC: CNVVY) to GBP2.94 (from GBP3.07) while maintaining a Overweight rating.

ConvaTec Group Plc. (CTEC:LN) (CNVVY) PT Lowered to GBP2.30 at Citi

Mon, 18 May 2026 05:19:18 -0400

Citi analyst Veronika Dubajova lowered the price target on ConvaTec Group Plc. (CTEC:LN) (OTC: CNVVY) to GBP2.30 (from GBP2.50) while maintaining a Neutral rating.

ConvaTec Group Plc. (CTEC:LN) (CNVVY) PT Lowered to GBP2.30 at Citi

Mon, 18 May 2026 05:19:18 -0400

Citi analyst Veronika Dubajova lowered the price target on ConvaTec Group Plc. (CTEC:LN) (OTC: CNVVY) to GBP2.30 (from GBP2.50) while maintaining a Neutral rating.

ConvaTec Group Plc. (CTEC:LN) (CNVVY) PT Lowered to GBP2.30 at Citi

Mon, 18 May 2026 05:19:18 -0400

Citi analyst Veronika Dubajova lowered the price target on ConvaTec Group Plc. (CTEC:LN) (OTC: CNVVY) to GBP2.30 (from GBP2.50) while maintaining a Neutral rating.